Amid a new strain of mpox, the Danish company is preparing to make millions of vaccine doses to supply to the world.

The directors of the vaccine maker said the offer from Permira and Nordic Capital was an attractive proposal and recommended that shareholders accept it.

Bavarian Nordic specializes in vaccines for infectious diseases and immuno-oncology therapies, with Jynneos being a featured vaccine. Jynneos, Bavarian's vaccine for smallpox and monkeypox, is the ...

Vaccine maker Bavarian Nordic on Monday said it has agreed in principle to a roughly $3 billion take-private offer from private equity firms Nordic Capital and Permira.

COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its ...

Shares in Bavarian Nordic - one of the few drug firms with an mpox vaccine - were up about 19% since market close on Aug. 13, the day before the WHO announcement.

That’s how many vaccine doses Bavarian Nordic says it can supply by the end of 2025. Two million of these will be available over the remainder of 2024, the company said, a figure that includes ...

Bavarian Nordic added 100 million kronor to its previous forecast, raising those expectations to DKK 1.4 billion to DKK 1.6 billion for the year. And the company is in talks with more countries to ...

COPENHAGEN, Denmark, July 1, 2024 – Bavarian Nordic today announced the conversion of its existing undrawn DKK 1 billion syndicated revolving credit facility (RCF) into a sustainability-linked ...

Explore Bavarian Nordic stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BVNRY.

In 2004, Bavarian Nordic was awarded its second U.S. Government contract, valued at $115 million, to continue advanced development of IMVAMUNE® including clinical trials in individuals with ...

Now, Bavarian Nordic has shared a glimpse at how the vaccine may fare against omicron, the variant that has swept the world since the company began the phase 2 trial. Omicron neutralizing antibody ...